Ranitidine Hydrochloride
Product Images NDC 0781-2865

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranitidine Hydrochloride (NDC 0781-2865). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

150mg Capsulex60

Label for Ranitidine Hydrochloride Capsules 150 mg by Sandoz Inc. The label states each capsule contains ranitidine hydrochloride USP equivalent to 150 mg ranitidine, with a total of 60 capsules in the package. Storage instructions, child-resistant closure, and dispensing notes are also visible, including the manufacturer's location in Princeton, NJ, and indication of the product's origin as India.*

FDA Label Image

300mgx30capsules

Label for Ranitidine Hydrochloride Capsules 300 mg by Sandoz Inc. The label states this bottle contains 30 capsules. It includes storage instructions, dosage note to see package insert, child-resistant packaging warning, and manufacture information noting the product is made in India and distributed by Sandoz Inc in Princeton, NJ.*

FDA Label Image

Chemicalstructure

Chemical structure of the active ingredient Ranitidine Hydrochloride, showing its molecular arrangement including functional groups and attachments.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.